Wynik wyszukiwania w bazie Polska Bibliografia Lekarska GBL

Zapytanie: DAVID
Liczba odnalezionych rekordów: 1



Przejście do opcji zmiany formatu | Wyświetlenie wyników w wersji do druku
1/1

Tytuł oryginału: Prescribing pattern of anti-seizure medications (ASMs): an evaluation of extent of xanthine co-medication.
Autorzy: Manjula Devi, David Joy, Kulkarni Chanda
Źródło: Pol. J. Pharmacol. 2002: 54 (3) s.285-291, il., tab., bibliogr. 27 poz.
Sygnatura GBL: 313,156

Hasła klasyfikacyjne GBL:
  • farmacja
  • pulmonologia
  • neurologia

    Typ dokumentu:
  • praca przeglądowa
  • tytuł obcojęzyczny

    Wskaźnik treści:
  • ludzie

    Streszczenie angielskie: This study was conducted to evaluate the prescribing pattern of anti-seizure medications (ASMs) at a tertiary care hospital. The extent and pattern of concurrently used medications for co-exiting illnesses was also studied. Attention was focussed in particular on co-existence of bronchial asthma with epilepsy and co-medication of ASMs with xanthines. The study was carried out at the Central Pharmaacy and at the Medical Records Department. Data analysis at the central pharmacy showed 3.98 p.c. prescriptions for ASMs, with maximum number for males. More drugs were prescribed during the second decade of life and there were 2.17 drugs per prescription. The data for pattern and extent of use of ASMs along with polutherapy and concurrently used medications revealed the highest number of prescriptions for phenytoin, maximum number with single ASM, and phenytoin with phenobarbitone as most frequently prescribed combination. Co-administartion of ASMs with respiratory medications was found in 2.47 p.c., with 38.8 p.c. prescriptions having xanthines prescribed in them. Xanthines, the well known CNS stimulants, a property attributed to their adenosine receptor antagonistic activity, are considered potential seizurogenic agents. The results of the present preliminary survey show an indirect evidence for co-existence of epilepsy with asthma along with the extent of co-medication of ASMs with xanthines. Results indicate the need for further studies to evaluate the consequences of co-medication of ASMs with xanthines.

    stosując format: